Dr. Rom S. Leidner, MD
Claim this profileProvidence Cancer Institute Franz Clinic
Studies Squamous Cell Carcinoma
Studies Cancer
14 reported clinical trials
30 drugs studied
Area of expertise
1Squamous Cell Carcinoma
Stage IV
Stage III
HPV 16 positive
2Cancer
Stage IV
HPV 16 positive
Stage III
Affiliated Hospitals
Clinical Trials Rom S. Leidner, MD is currently running
GB1211 + Pembrolizumab
for Melanoma and Head & Neck Cancer
The purpose of this study is to determine the objective response of GB1211 and pembrolizumab versus pembrolizumab and placebo in patients with advance metastatic melanoma or head and neck squamous cell carcinoma.
Recruiting0 awards Phase 211 criteria
BMS-986340 + Nivolumab/Docetaxel
for Cancer
This trial tests a new drug, BMS-986340, alone and with other cancer treatments (nivolumab and docetaxel) in patients with advanced solid tumors. The goal is to find out if it is safe and effective in treating these cancers.
Recruiting1 award Phase 1 & 26 criteria
More about Rom S. Leidner, MD
Clinical Trial Related4 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Rom S. Leidner, MD has experience with
- Pembrolizumab
- Ipilimumab
- HB-201
- HB-202
- ADP-A2M4
- DPV-001
Breakdown of trials Rom S. Leidner, MD has run
Squamous Cell Carcinoma
Cancer
Head and Neck Cancers
Melanoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rom S. Leidner, MD specialize in?
Rom S. Leidner, MD focuses on Squamous Cell Carcinoma and Cancer. In particular, much of their work with Squamous Cell Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is Rom S. Leidner, MD currently recruiting for clinical trials?
Yes, Rom S. Leidner, MD is currently recruiting for 8 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Rom S. Leidner, MD has studied deeply?
Yes, Rom S. Leidner, MD has studied treatments such as Pembrolizumab, Ipilimumab, HB-201.
What is the best way to schedule an appointment with Rom S. Leidner, MD?
Apply for one of the trials that Rom S. Leidner, MD is conducting.
What is the office address of Rom S. Leidner, MD?
The office of Rom S. Leidner, MD is located at: Providence Cancer Institute Franz Clinic, Portland, Oregon 97213 United States. This is the address for their practice at the Providence Cancer Institute Franz Clinic.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.